Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Inventor:
Lam; Patrick Yuk Sun
Address:
Chadds Ford, PA
No. of patents:
8
Patents:












Patent Number Title Of Patent Date Issued
6858616 Nitrogen containing heterobicycles as factor Xa inhibitors February 22, 2005
The present application describes nitrogen containing heterobicyclics and derivatives thereof, or pharmaceutically acceptable salt forms thereof, which are useful as inhibitors of factor Xa.
6503898 Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors January 7, 2003
This invention relates to substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors, to pharmaceutical compositions comprising such compounds, and to methods of using these compounds for treating viral infection. A representative compound of the in
6451999 1-(3-aminoindazol-5-yl)-3-butyl-cyclic urea useful as a HIV protease inhibitor September 17, 2002
The present invention relates to compounds of formula I: ##STR1##or pharmaceutically acceptable salt forms or prodrugs thereof, which are useful as inhibitors of HIV protease, and to pharmaceutical compositions and diagnostic kits comprising the same, and methods of using the same for
6413980 Nitrogen containing heterobicycles as factor Xa inhibitors July 2, 2002
The present application describes nitrogen containing heterobicyclics and derivatives thereof, or pharmaceutically acceptable salt forms thereof, which are useful as inhibitors of factor Xa.
6218386 A1-(3-aminoindazol-5-yl)-3 butyl-cyclic urea useful as a HIV protease inhibitor April 17, 2001
The present invention relates to compounds of formula I: ##STR1##or pharmaceutically acceptable salt forms or prodrugs thereof, which are useful as inhibitors of HIV protease, and to pharmaceutical compositions and diagnostic kits comprising the same, and methods of using the same for
5877170 Substitute caprolactams and derivatives thereof useful for treatment of HIV disease March 2, 1999
This invention relates to novel substituted caprolactams, including 4-azacaprolactams, and derivatives thereof which inhibit HIV protease and are useful for treatment of HIV disease. Also included in this invention are pharmaceutical compositions containing such caprolactams, and to
5811422 Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors September 22, 1998
This invention relates to substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors, to pharmaceutical compositions comprising such compounds, and to methods of using these compounds for treating viral infection. A representative compound of the in
5663333 Substituted 1,4-diazapine caprolactams useful for treatment of HIV disease September 2, 1997
This invention relates to novel substituted caprolactams, including 4-azacaprolactams, and derivatives thereof which inhibit HIV protease and are useful for treatment of HIV disease. Also included in this invention are pharmaceutical compositions containing such caprolactams, and to










 
 
  Recently Added Patents
Dose escalation enzyme replacement therapy for treating acid sphingomyelinase deficiency
Tracking data eye operating margin for steady state adaptation
Antennas and their coupling characteristics for wireless power transfer via magnetic coupling
Prevention and treatment of osteoarthritis
Preamplifier-to-channel communication in a storage device
Method and apparatus for policy-based network access control with arbitrary network access control frameworks
Radiation protective garment with forced ventilation and method
  Randomly Featured Patents
Cellulose ester graft polymer/acrylic co-polymer/amino resin water dispersible coating composition
Two-piece header
Individually operative roll blind type panorama roof
Apparatus and method for bending glass sheets
Lifting electromagnet
Low bandwidth video teleconferencing system and method
One end adjustable torque rod
Automatic instrument turn off/on for error correction
LED light source assembly
MALDI analysis using modified matrices with affinity groups for non-covalent binding with analytes